National Comprehensive Cancer Network

Interactive CME


Educational Events & Programs

NEW LOCATION!

NCCN ACADEMY DATE > Wednesday, March 22, 2017 > ENROLL NOW!

NCCN ACADEMY LOCATION > Rosen Shingle Creek · Gatlin D/E · Orlando, Florida

OVERVIEW

Pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider and payer perspective. Participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology and will gather valuable insights material to developing effective strategies for navigating the various constituencies in cancer care. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.

Professionals from marketing, sales, medical affairs, clinical research, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

Please check back often for additional updates regarding this program. If you have any questions, please contact Jennifer Tredwell.


Moderator:

Description: Cliff Goodman

Clifford Goodman, PhD
Senior Vice President
The Lewin Group

 

 

 

 

CURRICULUM*

7:30 – 8:00 AM
Breakfast and Registration


8:05 – 8:10 AM
Welcome
C. Lyn Fitzgerald, MJ
Senior Vice President, U.S. & Global Development

8:15 – 10:00 AM
Module I: Post Election Review: Cancer Care Under a New Administration

Panelists:
Randy Burkholder
Vice President, Policy and Research
PhRMA

Peter Garrett
Director, Office of Communications and Public Liaison
National Cancer Institute (NCI)

Kavita Patel, MD, MSHS
Nonresident Senior Fellow
Brookings Institution

Marc Samuels
Founder and CEO
ADVI

Greg Simon
Executive Director
White House Cancer Task Force

10:05 – 10:20 AM
Break

10:25 – 11:55 AM
Module II: Meet the NCCN Guidelines Panel Experts 

Panelists:
Al B. Benson III, MD FACP FASCO
Professor of Medicine
Associate Director for Cooperative Groups
Chair, NCCN Colon and Rectal Cancers Panels Member
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University

Mary B. Daly, MD, PhD, FACP
Chair, Department of Clinical Genetics
Chair, NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian Panel Member
NCCN Breast Cancer Risk Reduction Panel Member
NCCN Breast Cancer Screening and Diagnosis Panel Member
Fox Chase Cancer Center

David Pfister, MD
Chief, Head and Neck Oncology Service
Chair, NCCN Guidelines for Head and Neck Cancers Panel
Memorial Sloan Kettering Cancer Center

Elizabeth Plimack, MD, MS
Chief, Division of Genitourinary Medical Oncology
Director, Genitourinary Clinical Research
Associate Professor, Department of Hematology/Oncology
NCCN Guidelines for Bladder/Penile Cancers
Prostate Cancer Panel Member
Fox Chase Cancer Center

Ruben Mesa, MD, FACP
Chair, Division of Hematology & Medical Oncology
Deputy Director, Mayo Clinic Cancer Center
Chair, Arizona Cancer Coalition
Professor of Medicine
Chair, NCCN Guidelines for Myeloproliferative Neoplasms Panel
Mayo Clinic Cancer Center

12:00 – 12:45 PM
Lunch

12:50 – 2:20 PM
Module III: Perspectives on the State of Cancer Care from Patients to Providers to Employers

Panelists:
Marcus Neubauer, MD
Vice President and Medical Director Value Based Reimbursement
McKesson Specialty Health

Lee N. Newcomer, MD
Senior Vice President, Oncology and Genetics
UnitedHealthcare

Thomas A. Sondergeld
Vice President Global Benefits & Mobility
Walgreens Boots Alliance

Laurel Todd
Vice President, Healthcare Policy and Research
Biotechnology Innovation Organization (BIO)

Lee Tomlinson
Patient Centered Care Advocate

Clorinda Walley
Executive Director
Good Days

2:25 – 3:30 PM
Closing Remarks
Gary J. Weyhmuller, MBA, SPHR
Executive Vice President, Chief Operating Officer
National Comprehensive Cancer Network

*Subject to change.


PROGRAM LOCATION

Rosen Shingle Creek
Gatlin D/E
9939 Universal Blvd
Orlando, FL 32819
View video here.

INTENDED AUDIENCE

Professionals from marketing, sales, medical affairs, clinical research, policy and government affairs, and other business areas.

TUITION INFORMATION

Academy Alumni

$895

All Industry Registrants 

$1,295

NCCN Corporate Council Member

$1,195

Ten or more people from the same company

$1,050

ACCOMMODATIONS

Click here for more information.


License NCCN Academy Video Modules!

Permission licenses are available to purchase exclusive video footage of recent NCCN Academy for Excellence & Leadership in Oncology™ School of Pharmaceutical & Biotech Business programs for viewing by internal company representatives for one year.

Customize your own NCCN Academy curriculum.

NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests


Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.